Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Operating Expenses (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Operating Expenses data on record, last reported at $21.7 million in Q3 2025.

  • For Q3 2025, Operating Expenses rose 21.75% year-over-year to $21.7 million; the TTM value through Sep 2025 reached $80.6 million, up 7.86%, while the annual FY2024 figure was $73.9 million, 2.97% up from the prior year.
  • Operating Expenses reached $21.7 million in Q3 2025 per ASMB's latest filing, up from $20.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $62.9 million in Q4 2021 and bottomed at $15.0 million in Q3 2023.
  • Average Operating Expenses over 5 years is $23.2 million, with a median of $20.7 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: soared 54.6% in 2021, then crashed 63.46% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $62.9 million in 2021, then plummeted by 63.46% to $23.0 million in 2022, then fell by 14.2% to $19.7 million in 2023, then decreased by 4.18% to $18.9 million in 2024, then grew by 14.73% to $21.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $21.7 million in Q3 2025, $20.7 million in Q2 2025, and $19.4 million in Q1 2025.